Document is current
Any future updates will be listed below
-
Authors
Selvakumar, Purushotham
Fernández-Mariño, Ana I.
Khanra, Nandish
He, Changhao
Paquette, Alice J.
Wang, Bing
Huang, Ruiqi
Smider, Vaughn V.
Rice, William J. https://orcid.org/0000-0002-5187-255X
Swartz, Kenton J. https://orcid.org/0000-0003-3419-0765
Meyerson, Joel R. https://orcid.org/0000-0002-6127-0093
-
Funding
Funding for this research was provided by:
Leon Levy Foundation (n/a)
- License Information
-
More Information
Article History
Received: 9 January 2022
Accepted: 7 June 2022
First Online: 4 July 2022
Competing interests
: V.V.S. and R.H. have an equity interest in Minotaur Therapeutics which has a license to the MNT-002 molecule. The authors declare no other competing interests.
